Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01203462 · ClinicalTrials.gov registry record · Phase 3
The PRIDE Study Probiotics on Regulation and Improving Digestive hEalth
A Phase 3 study, sponsored by Georgetown University.
- Completed
- Registry status
- Phase 3
- Development phase
- 68
- Enrollment target
NCT01203462 is a Phase 3 study that has completed, run by Georgetown University. The registered enrollment target is 68 participants.
The verdict
NCT01203462, a Phase 3 study, has completed, sponsored by Georgetown University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 68 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effect of probiotic supplemented yogurt in reducing colonic transit time (CTT) in females between the ages of 18-65 years old. Two yogurts will be administered, one containing a specific strain of probiotic in the Bifidobacterium genus and the other without the probiotic supplement. It is hypothesized that subjects receiving the probiotic supplemented yogurt will experience reduced CTT and improved gastrointestinal comfort and quality of life compared to those receiving the non-probiotic supplemented yogurt.
Interventions
- OTHER Probiotic strain of Bifidobacterium
- OTHER No Bifidobacterium
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01203462
The ClinicalTrials.gov registry entry for NCT01203462 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 68 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Georgetown University, which has 227 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Probiotic strain of Bifidobacterium is the first listed.
NCT01203462 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01203462 about?
NCT01203462 is a clinical study titled "The PRIDE Study Probiotics on Regulation and Improving Digestive hEalth". The purpose of this study is to determine the effect of probiotic supplemented yogurt in reducing colonic transit time (CTT) in females between the ages of 18-65 years old. Two yogurts will be administered, one containing a specific strain of probiotic in the Bifidobacterium genus and the other with...
What is the current status of trial NCT01203462?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 68 participants. The study started on 2010-10. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01203462?
The interventions under investigation include: Probiotic strain of Bifidobacterium (OTHER), No Bifidobacterium (OTHER).
Who is sponsoring clinical trial NCT01203462?
This trial is sponsored by Georgetown University, which has 227 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.